Stage of cirrhosis predicts the risk of liver-related death in patients with low model for end-stage liver disease scores and cirrhosis awaiting liver transplantation

Liver Transplantation

Volumn 20, Issue 10, 2014, Pages 1193-1201

  Wedd, Joel ^a   Bambha, Kiran M ^a   Stotts, Matt ^d   Laskey, Heather ^a   Colmenero, Jordi ^a,e   Gralla, Jane ^b,c   Biggins, Scott W ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; SODIUM;

ACUTE KIDNEY FAILURE; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BLEEDING; CASE CONTROL STUDY; CAUSE OF DEATH; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DETERIORATION; EMPYEMA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH INSURANCE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG ABSCESS; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PNEUMONIA; RISK ASSESSMENT; RISK REDUCTION; SEPSIS; SOCIAL STATUS; SODIUM BLOOD LEVEL; VARICOSIS; ADOLESCENT; AGED; COMPLICATION; EPIDEMIOLOGY; LIVER FAILURE; MIDDLE AGED; MORTALITY; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SURVIVAL RATE; TIME; TRENDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; COLORADO; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, STATISTICAL; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; WAITING LISTS; YOUNG ADULT;

EID: 84908500684     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23929     Document Type: Article

References (20)

1. Biggins SW, Bambha K. MELD-based liver allocation: who is underserved? Semin Liver Dis 2006;26:211-220.
2. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al.; for UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8: 851-858.
3. Olthoff KM, Brown RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl 2004;10(suppl 2):A6-A22.
4. Wiesner R, Lake JR, Freeman RB, Gish RG. Model for End-Stage Liver Disease (MELD) exception guidelines. Liver Transpl 2006;12(suppl 3):S85-S87.
5. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R; for United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10: 7-15.
6. Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, et al. Occurrence of cirrhosis-related complications is a timedependent prognostic predictor independent of baseline Model for End-Stage Liver Disease score. Liver Int 2006; 26:55-61.
7. Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW. Moderate ascites identifies patients with low Model for End-Stage Liver Disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl 2011;17:129-136.
8. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802-810.
9. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44: 217-231.
10. D'Amico G, Villanueva C, Burrohs AK, Dollinger MM, Planas R, Sola R, et al. AASLD Abstracts. Hepatology 2010; 52(suppl):329A.
11. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018-1026.
12. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258-266.
13. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397-417.
14. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis. a position statement based on the EASL special conference 2013. J Hepatol 2014;60:1310-1324.
15. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-313.
16. Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int 2012;32:1407-1414.
17. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130:1652-1660.
18. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005;41:32-39.
19. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11:336-343.
20. Saab S, Nieto JM, Lewis SK, Runyon BA. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev 2006:CD004889.